Pharmacy

Cincinnati, Ohio-based Mercy Health has saved more than $42 million on drugs since 2010 by building a formulary within its electronic health record platform.

California voters will weigh in this November on a high-stakes ballot proposition intended to help control the cost of prescription drugs - the latest attempt to limit soaring prices that have prompted public criticism nationwide.

Donald Trump is calling for a change in the way Medicare deals with big pharma prices, a revision long targeted by Democrats.

Biopharmaceutical company Emmaus Life Sciences has raised approximately $1.7 million in gross proceeds from the sale of common shares to Korea Bio Medical Science Institute as part of a collaboration agreement between the two companies.

The United States Department of Justice has given its blessing to a district court in New York to allow ex-pharmaceutical CEO Martin Shkreli to travel to Washington, D.C. to testify at a hearing on drug pricing on February 4.

The Centers for Medicare and Medicaid Services on Thursday finalized a rule on the rebate and reimbursement of prescription drugs, a move aimed at bringing down consumer costs and which is expected to save federal and state governments an estimated $2.7 billion over five years.

Kenneth Johnson, 49, is one of three found guilty following a 2014 trial and an investigation authorities dubbed "Operation Psyched Out".

Ireland-based Shire and Illinois-based Baxalta announced Monday they will be joining forces, merging in a deal estimated to be worth about $32 billion.

Investors are gathering in San Francisco this week for the annual J.P. Morgan healthcare conference, the sector's biggest financial event and one where many biotech deals are expected to be announced.

Doctors, providers and other stakeholders have until Monday to submit comment on new Centers for Disease Control and Prevention guidelines for prescribing opioids for chronic pain.